Urotensin Ⅱ receptor antagonist(urantide) alleviates renal injury in rats with atherosclerosis

Urotensin Ⅱ receptor antagonist(urantide) alleviates renal injury in rats with atherosclerosis

Objective To explore the mechanism of action of urantide in ameliorating renal injury caused by atherosclerosis(AS). Methods The rats were divided into normal group, model group which were treated with ip VitD3 150 U/(kg·d-1) for 3 consecutive days, and fed with high-fat special diet, with an experi...

Full description

Bibliographic Details
Main Author:	LIU Yifei, WANG Xinyu, WANG Jiahui, DU Xiaobing, WANG Tu, ZHAO Juan
Format:	Article
Language:	zho
Published:	Institute of Basic Medical Sciences and Peking Union Medical College Hospital, Chinese Academy of Medical Sciences / Peking Union Medical College. 2023-11-01
Series:	Jichu yixue yu linchuang
Subjects:	atherosclerosis\|urotensin ⅱ\|urantide\|renal injury\|jak2/stat3 pathway
Online Access:	http://journal11.magtechjournal.com/Jwk_jcyxylc/fileup/1001-6325/PDF/1001-6325-2023-43-11-1668.pdf

Similar Items

Effects of urotensin II receptor antagonist, GSK1440115, in asthma
by: Alison D Portnoy, et al.
Published: (2013-04-01)

Urotensin II Enhances Advanced Aortic Atherosclerosis Formation and Delays Plaque Regression in Hyperlipidemic Rabbits
by: Qingqing Yu, et al.
Published: (2023-02-01)

The Urotensin II System And Carotid Atherosclerosis: A Role In Vascular Calcification
by: Isabella eAlbanese, et al.
Published: (2016-06-01)

The Effect of Silymarin on the Expression of Urotensin–II and Urotensin–II Receptor Genes in the Liver Tissue of Type 2 Diabetic Rats
by: N Kheiripour, et al.
Published: (2019-12-01)

The Effect of Silymarin on the Expression of Urotensin–II and Urotensin–II Receptor Genes in the Liver Tissue of Type 2 Diabetic Rats
by: N Kheiripour, et al.
Published: (2019-04-01)

A new therapeutic approach to erectile dysfunction: urotensin-II receptor high affinity agonist ligands
by: Roberta d'Emmanuele di Villa Bianca, et al.
Published: (2015-02-01)

Serum Urotensin II Levels Are Elevated in Patients with Obstructive Sleep Apnea
by: Ante Mihovilovic, et al.
Published: (2023-05-01)

Effects of CBD supplementation on ambulatory blood pressure and serum urotensin-II concentrations in Caucasian patients with essential hypertension: A sub-analysis of the HYPER-H21-4 trial
by: Marko Kumric, et al.
Published: (2023-08-01)

The value of urotensin II in patients with left-sided rheumatic valvular regurgitation
by: Ibrahim Elmadbouh, et al.
Published: (2017-06-01)

Urotensin-II, oxidative stress, and inflammation increase in hypertensive and resistant hypertensive patients
by: Eray Metin Guler, et al.
Published: (2021-04-01)

Relationship between cardiac rhythm disorders, serum urotensin ІІ and angiotensin ІІ levels in patients with stage ii hypertension and carotid atherosclerosis in dynamics of treatment with candesartan and lercanidipine
by: O. V. Demidenko,, et al.
Published: (2016-10-01)

The Role of Urotensin-II in Obesity and Metabolic Syndrome in Pediatric Population
by: Marko Simunovic, et al.
Published: (2022-02-01)

Expressions of irisin and urotensin II and their relationships with blood pressure in patients with preeclampsia
by: Li-Jie Zhang, et al.
Published: (2017-07-01)

Role of Urotensin-II in Saphenous Vein Graft Disease
by: Mehmet Erin Tüysüz, et al.
Published: (2020-06-01)

Combination of Docking-Based and Pharmacophore-Based Virtual Screening Identifies Novel Agonists That Target the Urotensin Receptor
by: Na Li, et al.
Published: (2022-12-01)

The relationship between anxiety and serum urotensin-II and S100B levels in patients with essential hypertension (eng)
by: Aslı Kazğan, et al.
Published: (2021-09-01)

Changes in the electrophysiological parameters of the posterior intestine of Anguilla anguilla (Pisces) induced by oxytocin, urotensin II and aldosterone
by: B. Baldisserotto, et al.
Published: (1997-01-01)

Urotensin II Induces ER Stress and EMT and Increase Extracellular Matrix Production in Renal Tubular Epithelial Cell in Early Diabetic Mice
by: Xin-Xin Pang, et al.
Published: (2016-07-01)

Divergent cardio-ventilatory and locomotor effects of centrally and peripherally administered urotensin II and urotensin II-related peptides in the unanesthethized trout
by: Gilmer eVanegas, et al.
Published: (2015-04-01)

Urotensin II Induces Mice Skeletal Muscle Atrophy Associated with Enhanced Autophagy and Inhibited Irisin Precursor (Fibronectin Type III Domain Containing 5) Expression in Chronic Renal Failure
by: Ya-Jing Pan, et al.
Published: (2019-06-01)

The urotensin II receptor antagonist DS37001789 ameliorates mortality in pressure-overload mice with heart failure
by: Mina Nishi, et al.
Published: (2020-02-01)

Urotensin II promotes the proliferation and secretion of vascular endothelial growth factor in rat dermal papilla cells by activating the Wnt-β-catenin signaling pathway
by: Congjuan Liao, et al.
Published: (2023-06-01)

An investigation of postmortem urotensin II receptor levels in brain and kidney tissues in a rat model of cardiac ischemia
by: Mustafa Talip Sener, et al.
Published: (2018-01-01)

Targeting the Urotensin II/UT G Protein-Coupled Receptor to Counteract Angiogenesis and Mesenchymal Hypoxia/Necrosis in Glioblastoma
by: Vadim Le Joncour, et al.
Published: (2021-04-01)

Urotensin II-related peptides, Urp1 and Urp2, control zebrafish spine morphology
by: Elizabeth A Bearce, et al.
Published: (2022-12-01)

The G Protein-Coupled Receptor UT of the Neuropeptide Urotensin II Displays Structural and Functional Chemokine Features
by: Hélène Castel, et al.
Published: (2017-04-01)

Smad2/3 signaling involved in urotensin II-induced phenotypic differentiation, collagen synthesis and migration of rat aortic adventitial fibroblasts
by: Weizhao Lin, et al.
Published: (2023-08-01)

Effects of Thymoquinone on Urotensin-II and TGF-β1 Levels in Model of Osteonecrosis in Rats
by: Mehmet Yilmaz, et al.
Published: (2023-10-01)

Urotensin II promotes secretion of LTB4 through 5-lipoxygenase via the UT-ROS-Akt pathway in RAW264.7 macrophages
by: Dan Lu, et al.
Published: (2019-05-01)

Inhibition of JAK2/STAT3/SOCS3 signaling attenuates atherosclerosis in rabbit
by: Xilan Yang, et al.
Published: (2020-03-01)

Impact of Classic Adrenal Secretagogues on mRNA Levels of Urotensin II and Its Receptor in Adrenal Gland of Rats
by: Karol Jopek, et al.
Published: (2023-08-01)

Conserved role of the urotensin II receptor 4 signalling pathway to control body straightness in a tetrapod
by: Faredin Alejevski, et al.
Published: (2021-08-01)

Urotensin-II and endothelin-I levels after contrast media administration in patients undergoing percutaneous coronary interventions
by: Turgay Ulas, et al.
Published: (2013-01-01)

Chronic Urotensin-II Administration Improves Whole-Body Glucose Tolerance in High-Fat Diet-Fed Mice
by: Xi Chen, et al.
Published: (2019-07-01)

JAK/STAT in leukemia: a clinical update
by: Dong Liang, et al.
Published: (2024-01-01)

Features of 24-hour monitoring of blood pressure, serum urotensin II and angiotensin II levels, vascular remodeling and extracranial blood flow in patients with hypertension
by: V. A. Vizir, et al.
Published: (2015-12-01)

Protective effect of urotensin II receptor antagonist urantide and exercise training on doxorubicin-induced cardiotoxicity
by: Jing Sun, et al.
Published: (2023-01-01)

Oxidative parameters, oxidative DNA damage, and urotensin-II in schizoaffective disorder patients
by: Osman Hasan Tahsin Kilic, et al.
Published: (2019-04-01)

Effect of urotensin II on apolipoprotein B 100 and apolipoprotein A-I expression in HepG2 cell line
by: Abbas Mohammadi, et al.
Published: (2014-01-01)

Boy kısalığı olan çocukların serum ürotensin 2 düzeylerinin igf-1 ile ilişkisi
by: Döndü Ülker Üstebay, et al.
Published: (2019-12-01)